Citadel Advisors’s DARA BIOSCIENCES INC COM STK (DE) DARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-59,655
Closed -$51K 9764
2015
Q3
$51K Sell
59,655
-22,032
-27% -$19K ﹤0.01% 7576
2015
Q2
$74K Buy
81,687
+56,889
+229% +$46.9K ﹤0.01% 7379
2015
Q1
$18K Buy
+24,798
New +$20.8K ﹤0.01% 8002
2014
Q1
Sell
-2,738
Closed -$7K 8282
2013
Q4
$7K Sell
2,738
-2,489
-48% -$6.5K ﹤0.01% 6795
2013
Q3
$13K Buy
5,227
+964
+23% +$2.74K ﹤0.01% 6410
2013
Q2
$13K Buy
+4,263
New +$15.8K ﹤0.01% 6185

Citadel Advisors's DARA Position: Q4 2015 in Review

Citadel Advisors sold out of DARA BIOSCIENCES INC COM STK (DE) (DARA) in Q4 2015, closing a stake of 59,655 shares — an estimated $51K sold.

Citadel Advisors first reported a position in DARA in Q2 2013 and held it in 6 quarters. The position peaked at $74K in Q2 2015. 0 funds tracked by Wall St. Rank hold DARA as of Q4 2015.

  • Citadel Advisors reported no remaining DARA BIOSCIENCES INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Citadel Advisors sold 59,655 DARA BIOSCIENCES INC COM STK (DE) shares in Q4 2015, an estimated $51K.
  • Citadel Advisors first reported a position in DARA BIOSCIENCES INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Citadel Advisors's DARA BIOSCIENCES INC COM STK (DE) position peaked at $74K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held DARA BIOSCIENCES INC COM STK (DE) as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.